Fragment screening is becoming widely accepted as a technique to identify hit compounds for the development of novel lead compounds. In neighboring laboratories, we have recently, and independently, performed a fragment screening campaign on the HIV-1 integrase core domain (IN) using similar commercially purchased fragment libraries. The two campaigns used different screening methods for the preliminary identification of fragment hits; one used saturation transfer difference nuclear magnetic resonance spectroscopy (STD-NMR), and the other used surface plasmon resonance (SPR) spectroscopy. Both initial screens were followed by X-ray crystallography. Using the STD-NMR/X-ray approach, 15 IN/fragment complexes were identified, whereas the SPR/X-ray approach found 6 complexes. In this article, we compare the approaches that were taken by each group and the results obtained, and we look at what factors could potentially influence the final results. We find that despite using different approaches with little overlap of initial hits, both approaches identified binding sites on IN that provided a basis for fragment-based lead discovery and further lead development. Comparison of hits identified in the two studies highlights a key role for both the conditions under which fragment binding is measured and the criteria selected to classify hits.
Introduction
Fragment-based lead discovery (FBLD), often also called fragment-based drug discovery (FBDD), is evolving as a robust method to identify hit molecules for drug development. [1] [2] [3] An increasing number of compounds derived from fragment-based methods have progressed into clinical development targeting a variety of targets, including enzymes such as proteases, kinases, and polymerases (reviewed in Murray and Blundell 3 ). FBLD methods use low molecular weight compounds ("fragments") to probe pockets in the target protein. Fragments were initially described by a "rule of three": having a molecular weight of less than three hundred Daltons with up to three rotatable bonds, no more than three hydrogen bond donors or acceptors, and a calculated partition coefficient (clogP) of three or less. 4 Modern fragment libraries now contain compounds much smaller than 300 Da to maximize the chemical diversity of a library. As fragments generally bind weakly to the target, sensitive biophysical techniques are required to identify a binding event, and multiple different biophysical assays are often used in conjunction to confirm binding.
The biophysical techniques that are used most commonly (either individually or in combination) to identify and confirm fragment hits are nuclear magnetic resonance (NMR), surface plasmon resonance (SPR), thermal shift assays, and X-ray crystallography. Each technique provides different information about compound binding and complements the other methods.
NMR is a powerful and sensitive method for hit detection, and a number of distinct experimental methods can be used for FBLD. For example, researchers at Abbott, who pioneered the FBLD approach with "SAR by NMR," 5 used a number of different NMR techniques-initially reporting screening using 15 N-heteronuclear single-quantum coherence (HSQC) experiments, which required 15 N-labeled protein. In a subsequent study, they used a WaterLOGSY method 6 that did not require labeled protein and could be undertaken at lower protein concentrations. A strength of the 15 N-HSQC method is that it identifies whether binding has occurred and also the location of the fragment binding site in a single experiment. A disadvantage of this method is the need for significant amounts of 15 N-labeled protein. For saturation transfer difference nuclear magnetic resonance spectroscopy (STD-NMR), 7 the protein is magnetized via spin diffusion, and the magnetization is transferred selectively to protein-bound ligands and detected on the free ligand following dissociation. This approach offers similar advantages to the WaterLOGSY method, although STD-NMR and WaterLOGSY do not provide any direct information about the binding location, so secondary screening techniques are required.
SPR offers another sensitive means of identifying hits. Proteins are immobilized on a surface where interactions between the compound and protein are measured through changes in the reflection angle of polarized light. Although no structural information is obtained, a benefit of this technique is that the binding affinity of the compound and, in certain cases, kinetic data in the form of both on-rates and off-rates can be determined.
Although several companies, including ActiveSight, Plexxikon, Zenobia, and DeCODE, have used X-ray crystallography for both fragment screening and structural characterization, X-ray crystallography is most often used following the preliminary screen to obtain detailed information about protein-ligand interactions. In many cases, crystallography can effectively identify very weak protein-ligand interactions, but a range of factors may prevent the formation of protein/fragment complexes. First, the protein crystallization conditions may differ significantly from the biologically relevant environment (e.g., the crystals may only grow at a pH well removed from physiological pH). The most common FBLD approach, soaking, involves incubating preformed protein crystals in a liquor containing the fragment and assumes that the fragment will diffuse into the crystal and bind to the protein molecules therein in the same way that it would bind to protein molecules in solution. In this case, crystal contacts may prevent access to binding sites, or the crystal lattice may prevent conformational change in the protein necessary for binding. Co-crystallization, growing protein crystals in the presence of compound, can overcome these issues but is sometimes difficult and may require extensive crystallization screening for each compound. This may be due to conformational changes in the protein upon ligand binding, disrupting crystal contacts or changes in the system from addition of solvents such as DMSO that are commonly used to solubilize fragments.
Herein we report the independent efforts of our two groups to find novel inhibitors of the HIV-1 integrase core domain (IN) using a fragment-based screening approach. [8] [9] [10] IN is an essential protein in the life cycle of HIV. 11 The IN protein occurs as a dimer in vitro (K dimer of 67.8 pM) and is believed to act as either a dimer or a tetramer (a dimer of dimers) in vivo. 12 The first drug targeting IN, raltegravir, was granted Food and Drug Administration (FDA) approval in late 2007 for patients who were failing other anti-HIV treatments and further approval in 2009 for previously untreated patients. Raltegravir contains a di-carbonyl moiety that coordinates to the divalent metal ion that is present at the active site of IN; its mode of binding was visualized by crystallography in the related Prototype Foamy Virus IN. 13, 14 Mutations in IN that cause resistance against raltegravir have already emerged. These mutations also result in cross-resistance to other IN inhibitors that are progressing through the clinic, which bind to the same site as raltegravir and act via a similar mechanism. 15 Consequently, drugs that can target other sites on IN and that do not have the same resistance profiles to currently available drugs are of interest and would complement the current IN inhibitors used in the multidrug treatment regimes. Several potential inhibitor binding sites have been reported for IN (reviewed in Al-Mawsawi and Neamati 16 ), including the active site, the LEDGF binding site, 17, 18 the fragment binding pocket (FBP), 9 the sucrose binding pocket, 10 and a binding site located adjacent to the active site flexible loop (residues 140-149). 8, 19 The two screening campaigns used closely related, 500-compound fragment libraries purchased from Maybridge (Cornwall, UK). In Approach A, STD-NMR was used as a primary screen. Compounds were initially screened in pools consisting of 10 fragments, and the hits were then retested as single compounds. Confirmed hits from the individual STD-NMR experiments were advanced into crystallization trials, and binding in solution was confirmed by recording HSQC spectra of 15 N-labeled IN in the absence and presence of the fragment. In Approach B, the fragment library was screened individually at a single concentration using SPR, and initial hits were confirmed by further dosage response studies also using SPR and subsequently put into crystallization trials. We compare and contrast the results of the two studies and look at the implications for other FBLD projects.
Materials and Methods
The methods for Approaches A and B have been previously described by Wielens et al. 9 and Rhodes et al., 8 respectively, but will be summarized here briefly for comparison.
Mutagenesis. Four HIV-1 IN 50-212 constructs were used for the X-ray crystallography experiments. The welldescribed solubilizing mutations C56S, W131D, F139D, and F185H were introduced into a truncated HIV-1 IN 50-212 (NL-43 strain) sequence (IN CORE4H ) in a pET23b vector using oligonucleotide mutagenesis. In addition to the four solubilizing mutations, the second IN 50-212 construct (IN CORE4H123 ) contained changes at residue positions 123-127 from STTVK to GATVR. This second construct was more consistent with that used by Chen et al. 20 O, giving a final concentration of each fragment of ~1 mM. NMR data were collected at 800 MHz on a Bruker Avance spectrometer (Bruker-Biospin) at 10 °C. Saturation of the protein resonances was achieved by a 5-s train of Gaussian pulses centered at -1 ppm. For the reference spectra, a similar saturation pulse was applied 20 000 Hz off-resonance. A 20-ms spin-lock period was employed before acquisition to allow the residual protein signal to decay. Results were analyzed using TOPSPIN (Bruker BioSpin) by comparison of the STD spectra with 1D spectra of the individual compounds. Fragments that gave a positive STD signal in the cocktail were retested in the STD-NMR assay as individual compounds. 15 N-HSQC spectra. Where individual compounds gave a positive STD result, binding was confirmed by recording 15 N-HSQC experiments on uniformly 15 N-labeled IN CORE4H123 (0.15 mM) in the presence of single fragments (1 mM). Compounds were regarded as positive hits if chemical shift perturbations were observed in the HSQC spectrum upon addition of the fragment. Spectra were recorded at 600 and 800 MHz on a Varian Inova 600 or Bruker Avance 800 (Bruker-Biospin), respectively, both of which were equipped with cryogenically cooled probes.
Surface Plasmon Resonance
Immobilization of proteins. His 6 -IN CORE3H and His 6 -IN CORE4H proteins were immobilized onto a CM5 sensor chip using standard amine-coupling chemistry at 25 °C. HBS-P+ (10 mM HEPES, 150 mM NaCl, 0.05% [v/v] Tween-20, pH 7.4) was used as the running buffer. The carboxymethyl dextran surface was activated with a 7-min injection of a 1:1 ratio of 400 mM 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC)/100 mM N-hydroxysuccinimide (NHS). His 6 -IN CORE3H and His 6 -IN CORE4H were diluted in 10 mM sodium acetate (pH 5.0) to 20 µg/mL and coupled in separate flow cells with a 7-min injection. Remaining activated groups were blocked with a 7-min injection of 1M ethanolamine (pH 8.5). Plasmodium falciparum AMA1 recombinant protein, used as an unrelated reference protein, was immobilized on the same chip using a similar method as for the IN proteins except that AMA1 protein was diluted to 50 µg/mL in 10 mM sodium acetate (pH 4.5). Protein immobilization levels typically achieved were as follows: His 6 -IN CORE3H ~10 200 RU, His 6 -IN CORE4H = 11 500 RU, and AMA1 (62.5 kDa) = 9 700 RU. Fragment screening. The 10-mM fragment stocks were diluted a further 20-fold in 1.05 × HBS ICP -P+ (50 mM HEPES, 150 mM NaCl, 0.05% Tween-20, pH 7.4) screening buffer to obtain 500-µM fragment concentrations in 1 × HBS ICP -P+ buffer containing 5% (v/v) DMSO. Screening experiments were run at 20 °C with 1 × HBS ICP -P+ running buffer supplemented with 5% (v/v) DMSO. Compounds were screened using a 96-well format with an association and dissociation time of 60 s each. To assess the stability of the protein surface and to allow for accurate ranking of selected fragments, the best hit selected from the first 96-well screen was used as a positive control for the subsequent 96-well plates. Experiments were normalized to a R max of 100 RU using a normalization formula of (MW control /MW sample ) · (100/R max , control). 22 Hits that generated an SPR signal for IN that was two times larger than the response on the reference (AMA1) protein were considered as selective binders of IN. Hits were further ranked based on their normalized response against IN. A concentration series in 2-fold dilutions (31.25-500 µM) in 1 × HBS ICP -P+ buffer/5% DMSO under the same conditions as described above was used to confirm hits.
Data processing. Raw sensorgram data were reduced, solvent corrected, and double referenced using the Scrubber 2 software package (BioLogic Software, Campbell, Australia). Where appropriate, the binding affinity of the compounds was fit to a 1:1 steady-state affinity model.
Cross-validation of SPR hits. A subset of the fragments that were identified as hits in the initial SPR screen was subsequently reevaluated by both STD-NMR and SPR. For the NMR experiments, STD spectra were recorded using a slightly modified version of the protocol described above. Samples for STD contained single fragments (300 µM) and IN CORE4H (5 µM) in HEPES buffer (50 mM) containing NaCl (150 mM), Tween-20 (0.05% v/v), and 1% DMSO at two pH values of 7.4 and 8.5. SPR data were also acquired using the same buffer conditions, with IN CORE3H using the protocol described above. The fragments were initially tested at a single concentration (100 µM), and where a positive response was obtained, data were acquired for a concentration series in 2-fold dilutions (6.25-200 µM) containing 2% DMSO.
X-ray Crystallography
Crystallization. For Approach A, a 2-µL drop of 8 mg mL -1 IN CORE4H protein solution containing 25 mM HEPES (pH 6.5), 500 mM NaCl, and 5 mM DTT was mixed with an equal volume of reservoir solution that contained 1. 4 21 For Soaking experiments. For Approach A, stock solutions of fragments were made by dissolving each fragment in ethanol to 20 mM. Crystals of IN CORE4H or IN CORE4H123 were transferred to a drop containing 4 µL reservoir solution and 1 µL compound stock solution and incubated for 2 h to overnight. Prior to cryo-cooling, crystals were transferred to mother liquor containing reservoir solution, 4 mM fragment solution, and 25% (w/v) sucrose or 20% (v/v) glycerol. The X-ray diffraction data were collected on either the GMCA-CAT 23-IDB or 23-IDD beamlines at the Advanced Photon Source (Argonne, IL) or the MX beamlines at the Australian Synchrotron (Clayton, Victoria, Australia).
For Approach B, fragments in neat DMSO were added to the cryo-solution so that the DMSO-fragment solution was at 5% (a 1/20 dilution), and then 1.2 µL of this was added to drops containing crystals. Twenty-four to 48 h later, the crystals were taken to the MX1 beamline at the Australian Synchrotron for data collection. MicroLoops (MiTeGen, Ithaca, NY) were used to gently remove the crystal from the drop, and the crystals were cryo-cooled in the cold nitrogen stream of the beamline.
Data collection. All diffraction data were collected using the BLU-ICE interface 23 and indexed with Mosflm 24 or XDS 25 and scaled with XDS or Scala. 26 Structures were solved by molecular replacement with AMoRE 27 or Phaser 28 as previously described. [8] [9] [10] In Approach A, compounds were built in MarvinSketch (ChemAxon, Cambridge, MA) and parameterized using Monomer Library Sketcher in CCP4. 26 In Approach B, 3D models of the fragments were generated and placed in density using AFITT (OpenEye Scientific Software, Sante Fe, NM). Refinement was completed using Refmac5 29 and Phenix.refine, 28 from the CCP4 26 and PHENIX 28 suites, respectively. Manual model building was performed using Coot. 30 The quality of the final models was evaluated with Molprobity. 31 Final refinement statistics and Protein Databank accession codes are shown in Table 1 .
Figures were prepared with PyMOL (www.pymol.org). Chemoinformatics and analysis of chemical library properties were undertaken using Instant JChem (ChemAxon), CDD (Burlingame, CA), and the Benchware 3D Dataminer Suite (ACDLabs, Toronto, Ontario, Canada).
Results
Two independent groups embarked on an FBLD campaign targeting HIV-1 IN using different approaches. Approach A used NMR as the primary screening tool, whereas in Approach B, SPR was used for preliminary screening ( Table 2) . In both cases, hits were then investigated by crystallography. Compounds from both approaches that resulted in an IN/fragment complex are shown in Figure 1 .
The Fragment Libraries
Two Rule-of-3 (Ro3) Diversity fragment libraries (Set A and Set B), each containing 500 compounds, were purchased from Maybridge about 6 months apart. The difference in purchase dates resulted in a content variation of approximately 10% between the two libraries (455 compounds in common between the two sets). Analysis of both fragment libraries showed that compounds had an average molecular weight of 189.0 Da and a calculated partition coefficient (cLogP) of 1.4. The average number of rotatable bonds was 1.8, the average number of hydrogen bond acceptors was 2.5 and 2.6, and the average number of hydrogen bond donors was 1.0 for libraries A and B, respectively. The libraries contained good diversity with 413 clusters identified (maximum cluster size of three compounds in four cases) using a Tanimoto cutoff of 85% similarity. Compounds typically comprised a 5,6 or 6,6 fused or linked ring system with one or two functional groups. Many are electron rich, containing two or more heteroatoms. Of those that contained a chiral center, it was assumed that both isomers were present.
Approach A
In Approach A, fragments were grouped into cocktails of 10 and screened against IN CORE4H at a concentration of ~1 mM (based on an average molecular mass of 189 Da). Thirty-three cocktails contained positive responses, and from these, 84 compounds were identified in the preliminary STD-NMR screen. A second STD-NMR screen was performed where fragments that gave a positive STD in the mixtures were rescreened as singletons. This resulted in 51 compounds that gave a clear positive STD response and a further 11 fragments that gave a weak or very weak (borderline) response (Suppl. Fig. S1A-C) . Binding of these 62 fragments to IN was confirmed by recording 15 N-HSQC spectra in the absence and presence of individual fragments (1 mM). Compounds that induced perturbations in the HSQC spectrum were considered to be validated as binding to IN (Suppl. Fig. S1D ). All 62 compounds (Suppl. In total, 15 well-defined IN/fragment complexes were obtained (Fig. 2, 1-15 ).
Approach B
In Approach B, compounds were individually screened by SPR. Compounds that gave a signal two times larger than the response to the AMA1 reference cell were considered hits. Hits were confirmed by SPR using a 2-fold dilution concentration series before entering crystallization trials (Suppl. Fig. S3) . A total of 16 fragments from the library were considered from the SPR screening results (Suppl. Fig. S4 ). His 6 -IN CORE3H crystals were soaked in each of the hits, and six clear IN/fragment complexes were identified from single crystal experiments (Fig. 2, 63-68) . Mixed or unclear density was seen for 3 of the other 16 SPR hits.
Cross-Correlation of Results
The hits from the primary screen in each approach were compared, and the results of the comparison are summarized in Figure 3 . No compounds were found to be confirmed hits in both screening methods. Three compounds (64, 66, and 70) from Approach B were identified in the primary STD-NMR screen; however, these compounds were not confirmed in the follow-up STD-NMR assay. A crystal structure for only one of these common hits (64) was obtained. No fragment was found in a crystal structure by both groups. The lack of overlap between hits identified using the two approaches surprised us, especially considering chemically similar groups were identified among the hits. To understand this further, we reanalyzed the primary screening data and looked at compounds identified by SPR that were not identified in the NMR screen and vice versa.
Of the 16 fragments identified as hits in Approach B, 3 (65,  71, and 72) were insoluble under NMR conditions and were therefore excluded from testing. One (69) contained significant breakdown products in the 1D NMR spectra. The remaining 12 hits identified by SPR that gave 1D NMR spectra consistent with the structures shown were not classified as hits from the STD-NMR spectra acquired for the initial mixtures. Of the hits from Approach A that were confirmed by crystallography- eight (1, 2, 3, 7, 9, 10, 12, and 14) were found to hit both IN and AMA1 in the SPR assay. These compounds did not satisfy the selection criteria of giving a response upon binding to IN at least twice observed against AMA1 and were therefore excluded from further investigation. Two fragments (11 and 15) gave no discernible binding to either protein by SPR, and five fragments (4, 5, 6, 8, and 13) contained DMSO mismatches with a negative response on both channels.
Only one of the hits identified by SPR (64) showed any STD signal in the NMR experiments in Approach A. To address this apparent anomaly, the SPR hits were reevaluated in the NMR assay. Authentic samples were available for 12 of 16 fragments identified as hits by SPR, including 5 of 6 fragments that subsequently generated crystal structures (Suppl . Table S1 ). The samples were screened individually at a lower concentration (300 µM) to circumvent some of the solubility problems observed in the earlier screen and at two pH values of 7.4 and 8.5 to address the effects of pH on the outcome of screening. All of the compounds tested were soluble under the modified NMR conditions. Four of the 12 compounds tested gave clearly positive responses in the STD-NMR assay at both pH values. At pH 7.4, four of 12 gave a response in the STD-NMR that was classified as very weak/marginal, and four compounds showed no binding. At pH 8.5, two compounds gave very weak/marginal responses and six gave no binding.
The same compounds were reevaluated in parallel using SPR. All of the fragments gave a positive response when tested at a single concentration, although one (66) gave a profile consistent with a nonspecific aggregation-type binder 22 and was not tested further. Details of the rescreening are presented in Supplementary Table S1 .
Of the six compounds from Approach B for which crystal structures were obtained, five were available for retesting. Of these, four (63, 64, 67, and 68) gave clearly positive responses by STD-NMR; the other (66) gave a very weak STD response at pH 7.4 and no response at pH 8.5. Interestingly, this was also the compound that was classified as aggregated in the SPR screen. The SPR data were used to estimate K D values for the fragments, which were all found to bind with affinities >1 mM. Notwithstanding the difficulties inherent in estimating potencies of such weakly binding fragments, it is apparent that the initial hits for which crystal structures were subsequently obtained appear to be generally more potent. The compounds identified as hits by SPR in the initial screen that failed to give crystal structures gave either very weak or no response upon retesting by STD-NMR.
The difference in pH had very little effect on the results of the STD-NMR assay-the same four compounds gave clearly positive responses at the two pH values.
Discussion
Although ~90% of the fragments tested were identical for the fragment screening campaign from each group, we see that there is little overlap between the sets of hit fragments identified by the two approaches. Although some of the differences are easily understood, the lack of overlap between the two data sets is surprising, and it was initially thought that this may reflect in part the different conditions used in the two screening campaigns. The crystallization conditions were similar for the different proteins, all having precipitant solutions consisting of approximately 1.5M ammonium sulfate and a low pH acetate or citrate buffer (pH 4.6-5.6). In Approach A, CdCl 2 was a component of the crystallization conditions, whereas in Approach B, MgCl 2 was a component in the protein solution. Therefore, the initial selection of compounds from the screens done by NMR or SPR was probably the major contributor to the different results. A difference between the initial screens was the pH and buffer conditions under which the experiments were run; the NMR screen used Tris buffer at pH 8.5, and the SPR used HEPES buffer at pH 7.4. DMSO was present in both cases at about 1.5% for NMR and 5% for SPR, along with a small amount of detergent (CHAPS or Tween); NaCl was either 50 or 150 mM, and the fragment was present at either 1 or 0.5 mM (NMR and SPR, respectively). However, from the results of the rescreening hits by STD-NMR and SPR, we did not find any significant differences between the assays run at either pH (see Suppl. Table S1 ). Therefore, it appears that the selection criteria for classification of a hit in the different approaches, rather than the different conditions that were used, were a major reason for the lack of overlap.
Selection Criteria
The criteria used in Approach A for progressing hit compounds into X-ray crystallography were less stringent than Approach B, as even very weak binders from the STD-NMR results were considered. This was to obtain a greater understanding of compound binding to IN and to maximize compound diversity for further fragment optimization at a later stage. No requirement for selective binding to IN was imposed, and this likely reflects the higher number of fragments that were progressed to crystallography from Approach A. In contrast, for progression into X-ray crystallography by Approach B, compounds had to show a preference to binding IN over the reference AMA1 protein as well as a clear dose-response curve from secondary SPR screening. The AMA1 protein was used in a reference cell as it had previously been shown to give reliable SPR data during fragment screening and it was unrelated to IN, so one could therefore eliminate promiscuous binders from the pool of binding fragments, leaving fewer compounds to screen via crystallography. Thus, some specificity was built in from the start of the project.
Although both approaches were successful in identifying fragments that bound and in generating structural data to support further development of the fragments, there was a surprising lack of overlap between the results of the two campaigns. In some respects, IN is an atypical target-in addition to the active site of the enzyme, there have been several other binding sites reported, as described above. In such a case, it might be anticipated that a higher than usual hit rate would be observed in the screen. This was the case in Approach A, where STD-NMR was used as the binding assay and a hit rate of ~17% was observed in mixtures of fragments, and ~13% of the fragments in the library gave a positive STD response when tested individually. In contrast, the primary screen from Approach B yielded a hit rate of only ~3%. It is worth noting that in addition to the different biophysical techniques and solution conditions used to monitor binding, the criteria for defining a hit differed significantly in the two approaches. The addition of a selectivity filter in Approach B-such that fragments were only considered hits if the response against IN was twice as large as that observed for an off-target protein (AMA1)-removed half of the fragments for which crystal structures were subsequently obtained using the less stringent criteria of Approach A. Combined with the cases where DMSO mismatches were observed in the SPR assay, this provides an explanation for most of the fragment hits from Approach A not being classified as hits in Approach B. No such explanation was evident in the reverse comparison, where most of the compounds classified as hits in Approach B were present and identified as chemically correct in the NMR spectra of Approach A but did not give a positive STD result.
Rescreening a subset (12/15) of the Approach B hits in the NMR assay at a lower concentration identified four of these as hits. Eight of the 12 SPR hits were still classified as very weak/marginal or nonbinders by STD-NMR and would not have been followed up under the criteria of the initial screen. This may reflect a difference in the threshold for detecting binding under the conditions used for the different screening formats. In the case of the STD-NMR assay, it is apparent that screening of less complex mixtures at lower concentrations is likely to result in fewer false negatives that may arise due to insolubility or competition. Based on a hit rate of 17% observed in the NMR assay, most mixtures would contain two fragments that bound to IN, raising the possibility of competition, which may decrease the intensity of any observed STD.
Chemistry of Hits
Although the NMR and SPR screens failed to identify the same fragments as hits, some common chemical features are present in both sets of hits, for example, rings containing two oxygen atoms (9, 14, 63, and 65) . Both screens identified similar ring systems, which possibly arises because the FBP is small and can only accommodate either a single aromatic ring or 5,6 or 6,6-fused system. The library itself typically contains a selection of functional variation for each core. For example, the N-phenyl pyrazole (64) identified using Approach B is also present as the 2′-hydroxymethyl and the 2′-carboxylic acid (23) , with the latter being identified using Approach A. A more decorated N-phenyl pyrazole (13) was also identified using Approach A.
pH It is worth noting that all the crystallographic studies were carried out at acidic pH (pH 4.6-5.6). However, during screening, the SPR was run at pH 7.4 and the STD-NMR at pH 8.5 . For fragments 8, 12, 63, 65, 66, and 67 , which contain carboxylic acids, the calculated pKa is less than 4, suggesting that these compounds would be fully ionized under the conditions used for screening. Other carboxylic acid-containing fragments have pKa values as high as 4.7, suggesting that there should be a significant portion of the unionized form present under the conditions used for crystallography . Alcohols 1, 3, 5, 11, 13, 14, and 73 have calculated pKa values above 14, and phenol 9 has a calculated pKa of 9.8. All would be protonated in both screening and crystallographic conditions, whereas anilines 4, 6, 7, and 15 would be present as the free base having a calculated pKa below 4. In contrast, for the aliphatic amines (2, 7, 10, 64,  and 68) , their degree of protonation would change in the pH range 6 to 9. The calculated pKa of 64 varied significantly depending on the software used to calculate it; a pKa of 6.55 was calculated using InstantJchem versus 8.48 by Scifinder. Therefore, the extent of protonation of 64 could be different in the NMR screen, where it was observed as a weak hit, compared with the SPR and crystallization buffers in which it was a hit. Despite this, we have no evidence to support differences in ionization significantly influencing results. In contrast, with the exception of the aggregation-type binder, 66, no significant differences were observed when compounds were rescreened in both the STD-NMR and SPR at pH 7.4 or 8.5.
Binding Sites
Compounds were found to bind predominantly into the socalled fragment binding pocket (FBP), 9 although some of the fragments were also observed to bind at the LEDGF binding site (see below). Other binding locations were observed; however, these were typically isolated cases and involved contacts with neighboring proteins in the crystal lattice.
The IN dimer contains two equivalent FBPs and two equivalent LEDGF binding pockets, both located at the dimer interface of the IN CORE domain. The FBP site is a small hydrophobic pocket adjacent to the LEDGF binding site. 9 There are two equivalent binding sites per dimer: FBP1 comprises residues A105, G106, R107, W108, P109, V110, K111, A133, G134, I204, T206, and I208 from Monomer A and Y83, W108, N184, F185H, K186, R187, S195, G197, E198, I200, and V201 from Monomer B. FBP2 has the equivalent residues donated by the opposite monomers. The FBP is conserved in other structures of related integrases from ASV, SIV, HIV-2, and BIV and has been suggested to be a suitable site for targeting by small-molecule inhibitors of IN. 9, 32 The LEDGF binding pocket was first visualized by Cherepanov et al. 33 The central residues in IN involved in interacting with the LEDGF IN binding domain are D167, Q168, A169, E170, H171, and T174 (monomer A) and T124, T125, and Q95 (monomer B) or similar residues on the opposite monomer for the second LEDGF binding site. LEDGF has an important role in the docking of the integration complex onto the host chromatin DNA. Disruption of this binding event significantly hampers or prevents integration, making it an excellent target site for allosteric drug development.
In addition to the complexes for which well-defined density was observed for the bound fragment, we obtained numerous examples of crystal structures where weak or partial density was observed in either the fragment or LEDGF binding sites. These results could be from multiple orientations of the fragment in the binding pocket or partial occupancy of the binding site. Although binding orientations could sometimes be inferred from better defined examples or closely related fragments, these fragments were not considered suitable structures for final models.
Availability of Binding Sites due to Crystal Packing
Slightly different protein constructs were used by the two groups during screening, and protein crystallization and soaking experiments were performed under different conditions. As a consequence, it is possible that crystal packing had an influence on the results obtained (Fig. 4) . The packing of the IN CORE4H is such that one FBP and one LEDGF binding pocket are mostly obscured by a neighboring IN molecule in the crystal lattice. This resulted in the fragment being observed in only one of the two equivalent binding sites in the crystal structure in some instances. However, in the P3 2 (IN CORE4H123 ) and P3 1 (His 6 -IN CORE3H ) space group structures, both fragment binding sites and LEDGF binding sites are unobstructed and available to bind fragments. In these cases, any bound fragment was found in both FBP sites and adopted the same binding mode. The three FBP sites were accessible for fragment binding in the C2 (IN F185H ) space group structure; however, all three LEDGF binding sites were blocked by crystal neighbors, so this construct was not considered further.
This study highlights the sensitivity of different assay formats to the experimental conditions and assay design. It also reveals some of the strengths of different assay formats-for example, screening by STD-NMR allows the chemical authenticity of fragments to be established at the time of screening, whereas SPR allows relatively straightforward measurement of binding affinity. This reinforces the complementarity and value of using different biophysical assays for characterizing binding in the early stages of fragment screening campaigns. However, it also highlights the need to adopt a coordinated approach to analysis of the screening data-in the current example, the different selection criteria used to classify hits in the two approaches led to mutually exclusive sets of fragments. In our original screening, we saw no overlap of hits between the two approaches, and in such situations, one might elect to take both sets of hits forward. However, we showed on rescreening that there was significant overlap of hits between the two approaches. In this case, if one were to combine NMR and SPR data in the early stages of screening, it would allow the presence of a binding event to be detected, the chemical authenticity of the hit to be established, and an estimate of the binding affinity and therefore ligand efficiency of the fragment to be obtained.
